Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsHyun Jung Kim, MD
Clinical InstructorAbout
Research
Publications
2026
Clozapine-induced Myocarditis in Korea: Analysis of a Nationwide Database and Comparison to Other Countries
Lee J, Jeong H, Park J, Kang N, Jeong J, Kim S. Clozapine-induced Myocarditis in Korea: Analysis of a Nationwide Database and Comparison to Other Countries. Clinical Psychopharmacology And Neuroscience 2026 DOI: 10.9758/cpn.25.1356.Peer-Reviewed Original ResearchOtolith Deterioration: Factors Affecting Microvascular and Structural Integrity
Choi E, Park J, Kwon H, Jung I, Kim H, Choi J, Kim J. Otolith Deterioration: Factors Affecting Microvascular and Structural Integrity. Journal Of Clinical Neurology 2026, 22: 89-101. PMID: 41517816, PMCID: PMC12802077, DOI: 10.3988/jcn.2025.0439.Peer-Reviewed Original ResearchOtolith functionAssociated with ageOcular vestibular evoked myogenic potentialsFemale sexPositively associated with high-density lipoprotein cholesterolVestibular evoked myogenic potentialsHigh-density lipoprotein cholesterolTertiary referral centerBenign recurrent vertigoPersistent postural-perceptual dizzinessSystemic factorsPositively associated with female sexPostural-perceptual dizzinessCross-sectional studyPotential risk factorsPotential mechanismsMyogenic potentialsReferral centerRecurrent vertigoFree thyroxineLipoprotein cholesterolRisk factorsMultivariate modelGeneralized linear modelDizziness
2025
Intrinsic Neural Timescale Mediates Amyloid‐Related Apathy in Alzheimer’s Disease
Wang Y, Kim H, Zhang A, Zhu X, Goldberg T, Lee S. Intrinsic Neural Timescale Mediates Amyloid‐Related Apathy in Alzheimer’s Disease. Alzheimer's & Dementia 2025, 21: e108820. PMCID: PMC12725525, DOI: 10.1002/alz70861_108820.Peer-Reviewed Original ResearchIntrinsic neural timescalesNeural substratesRight caudateEffects of amyloidAlzheimer's Disease Neuroimaging InitiativeAlzheimer's diseaseNeuropsychiatric Inventory dataResting state fMRIApathetic symptomsRight precuneusPsychiatric disordersNeural mechanismsBrain regionsFalse discovery rate correctionAD participantsNeural timescalesFMRI dataSubcortical ROIsDepressionApathyMediated pathwayFMRICaudateClinical statusMultiple comparisonsDementia in older adults with schizophrenia: a 12-year analysis of prevalence, incidence, and treatment patterns in South Korea
Park J, Kim S, Jeong D, Choi J, Jeong H, Park A, Kim Y, Lee J, Kim S. Dementia in older adults with schizophrenia: a 12-year analysis of prevalence, incidence, and treatment patterns in South Korea. Schizophrenia 2025, 11: 134. PMID: 41233387, PMCID: PMC12615695, DOI: 10.1038/s41537-025-00680-4.Peer-Reviewed Original ResearchHealth Insurance Review and AssessmentOlder adultsElevated risk of dementiaElevated riskBurden of dementiaRisk of dementiaGrowing care demandsDementia prevalenceAnalysis of prevalenceNursing homesDementia subtypesHealthcare utilizationCare demandsVascular dementiaDementiaGeneral populationComorbidity burdenAlzheimer's diseaseIntegrated treatment strategyAnnual increasePrevalenceOlder schizophrenia patientsBurdenTreatment patternsSchizophrenia populationReversibility of immune checkpoint inhibitor-induced hypothyroidism.
Seo J, Kim M, Kang M, Jung E, Suh K, Kim J, Kim S, Kim J, Kim Y, Lee K, Kim J, Lee J, Cho S, Moon J. Reversibility of immune checkpoint inhibitor-induced hypothyroidism. Endocrine Related Cancer 2025, 32 PMID: 41200918, DOI: 10.1530/erc-25-0138.Peer-Reviewed Original ResearchConceptsImmune checkpoint inhibitorsEarly-stage cancerPatients treated with immune checkpoint inhibitorsImmune checkpoint inhibitor treatmentImmune-related adverse eventsMultivariate Cox regression analysisLow TSH levelsMedian Follow-UpCox regression analysisTertiary referral hospitalCheckpoint inhibitorsLT4 treatmentTSH levelsRetrospective studyLT4Adverse eventsFollow-upHypothyroidismReferral hospitalCancer treatmentPatientsLikelihood of recoveryCancerTreatmentRegression analysisPrognostic impact of GNRI-IPI score in octogenarians with diffuse large B-Cell lymphoma treated with R-CHOP
Jeong E, Park W, Seo J, Kang M, Jung E, Kim S, Suh K, Kim J, Kim S, Lee J, Kim J, Kim Y, Lee K, Kim J, Lee J, Bang S, Lee J. Prognostic impact of GNRI-IPI score in octogenarians with diffuse large B-Cell lymphoma treated with R-CHOP. Annals Of Hematology 2025, 104: 5867-5879. PMID: 41085685, PMCID: PMC12672595, DOI: 10.1007/s00277-025-06670-x.Peer-Reviewed Original ResearchMeSH KeywordsAged, 80 and overAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDoxorubicinFemaleGeriatric AssessmentHumansLymphoma, Large B-Cell, DiffuseMaleNutrition AssessmentPrednisonePrognosisRetrospective StudiesRituximabSurvival RateVincristineConceptsDiffuse large B-cell lymphomaProgression-free survivalGeriatric Nutritional Risk IndexOverall survivalR-CHOPPrognostic impactGrade 3Diffuse large B-cell lymphoma treated with R-CHOPAssociated with inferior progression-free survivalLow Geriatric Nutritional Risk IndexMedian relative dose intensityInferior progression-free survivalLarge B-cell lymphomaSeoul National University Bundang HospitalElderly DLBCL patientsFrequent dose reductionsRelative dose intensityAdvanced-stage diseaseB-cell lymphomaNutritional Risk IndexKaplan-Meier methodHighest grade 3Cox proportional hazards modelsProportional hazards modelIPI riskCOPS5 inhibition synergizes with the antitumor effect of trastuzumab by PTEN upregulation in HER2-amplified gastric cancer
Hwang S, Kim J, Park H, Aguirre A, Kim K, Choi S, Park W, Seo J, Chae H, Kang M, Jung E, Suh K, Kim S, Kim J, Kim Y, Kim J, Lee K. COPS5 inhibition synergizes with the antitumor effect of trastuzumab by PTEN upregulation in HER2-amplified gastric cancer. Gastric Cancer 2025, 28: 1144-1157. PMID: 41039054, DOI: 10.1007/s10120-025-01669-9.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAnimalsAntineoplastic Agents, ImmunologicalAntineoplastic Combined Chemotherapy ProtocolsCell Line, TumorCell ProliferationCOP9 Signalosome ComplexDrug SynergismFemaleGene AmplificationHumansMaleMiceMice, NudeMiddle AgedPTEN PhosphohydrolaseReceptor, ErbB-2Stomach NeoplasmsTrastuzumabUp-RegulationXenograft Model Antitumor AssaysConceptsEffect of trastuzumabSynergistic antiproliferative effectAntitumor effectGastric cancerHER2 amplificationAssociated with worse disease-free survivalXenograft modelPTEN expressionAntitumor effects of trastuzumabClinical relevanceAKT downstream pathwayAssociated with poor outcomesGC cell linesDisease-free survivalAntiproliferative effectsHER2-positive GCSynergistic antitumor effectCell linesMethodsThe Cancer Genome AtlasCSN5i-3Overall survivalAdenocarcinoma cohortPoor outcomeCancer Genome AtlasChemotherapy resistanceDiagnostic utility of Niigata Persistent Postural-Perceptual Dizziness (PPPD) Questionnaire (NPQ) for PPPD in comparison to dizziness handicap inventory.
Kim H, Park J, Kim J. Diagnostic utility of Niigata Persistent Postural-Perceptual Dizziness (PPPD) Questionnaire (NPQ) for PPPD in comparison to dizziness handicap inventory. Journal Of Vestibular Research 2025, 9574271251382800. PMID: 40986615, DOI: 10.1177/09574271251382800.Peer-Reviewed Original ResearchNiigata PPPD QuestionnaireDizziness Handicap InventoryPostural-perceptual dizzinessBeck Depression Inventory-IIPerceived Stress ScaleHandicap InventoryVestibular disordersPsychological symptomsInternal consistencyDHI subscalesForward-backward translation procedureBackgroundPersistent postural-perceptual dizzinessDizziness-related disabilityPersistent postural-perceptual dizzinessExcellent internal consistencyCut-off scorePeripheral vestibular disordersFunctional vestibular disorderBetween-group comparisonsStimulant subscaleStress ScaleCronbach's alphaDisorder groupEmotional subscaleKorean versionAlteration of HER2 Status Following Neoadjuvant Chemotherapy in Breast Cancer: A Clinicopathological Analysis Focusing on HER2-Low Status
Sung H, Kwon H, Bai K, Chung Y, Shin H, Kim E, Suh K, Kim S, Kim J, Park S. Alteration of HER2 Status Following Neoadjuvant Chemotherapy in Breast Cancer: A Clinicopathological Analysis Focusing on HER2-Low Status. Cancer Research And Treatment 2025 PMID: 40968607, DOI: 10.4143/crt.2025.761.Peer-Reviewed Original ResearchHER2-low statusNeoadjuvant chemotherapyHER2 discordanceHER2 statusClinical outcomesBreast cancerHER2-lowResidual diseaseClinicopathological characteristicsDiscordance rateHER2-low breast cancerResidual cancer burden classPathologic complete response rateClinical outcomes of patientsHormone receptorsClinicopathological characteristics of tumorsHR-positive subgroupPost-NAC samplesComplete response rateAxillary node metastasesDisease-free survivalHER2-positive statusSurgically resected specimensOutcomes of patientsBreast cancer patientsAlternating vertical nystagmus associated with Wernicke encephalopathy
Li C, Kim H, Choi J, Kim J. Alternating vertical nystagmus associated with Wernicke encephalopathy. Journal Of Neurology 2025, 272: 614. PMID: 40913217, DOI: 10.1007/s00415-025-13370-z.Peer-Reviewed Original Research